Locations:
SearchPlease join our staff as we participate or present in the following oral and poster presentations at the 2018 ASCO Annual Meeting
2:45-3:05 p.m.
Hall D1
EDUCATION SESSION:
My Patient Was Diagnosed with Nontargetable
Advanced Non-Small Cell Lung Cancer: What Now?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Assessment and diagnostics of newly diagnosed
patients with advanced non-small cell lung cancer
Nathan Pennell, MD, PhD – Speaker
3:05-3:25 p.m.
S100bc
EDUCATION SESSION:
Personalizing Postoperative Treatment for Head
and Neck Cancer Nodal disease in HPV-positive and HPV-negative
cancer: Who needs postoperative radiation?
Shlomo Koyfman, MD – Speaker
3:25-3:45 p.m.
E253c
CLINICAL PROBLEMS IN ONCOLOGY SESSION:
When Less Is More: Local-Regional Management
of Breast Cancer Is abbreviated radiation a reality?
Chirag Shah, MD – Speaker
3:45-3:57 p.m.
S102
ORAL ABSTRACT SESSION:
ALLELE: A consortium for prospective genomics
and functional diagnostics to guide patient care
and trial analysis in newly-diagnosed glioblastoma
Abstract 2003
Manmeet Ahluwalia, MD – Author
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients